Our website uses cookies to bring you an easy and personalised browsing experience. By continuing, you consent to our cookie policy on this device. For More info, please see our Privacy Statement

ICECaP 2022

ICECaP Adjuvant

Chris Sweeney

ICECaP Adjuvant Working Group

View Presentation

Health Economics

Richard De Abreu Lourenco

Health Economics

View Presentation

Harmonization

Anis Hamid

ICECaP Adjuvant Working Group

View Presentation

STOPCaP

Jayne Tierney

Health Economics

View Presentation

STOPCaP ASCO

Susan Halabi

STOPCaP: Prognostic Models and Surrogacy

View Presentation

ICECaP Biology Presentation to be uploaded after ESMO 2022

ICECaP 2021

Opening Remarks

Paul Villanti, Executive Director Programs, Movember

Chris Sweeney, ICECaP Principal Investigator, Medical Oncology, Dana-Farber Cancer Institute

ICECaP Updates

Chris Sweeney

ICECaP Principal Investigator,
Medical Oncology,
Dana-Farber Cancer Institute.

View Presentation

Update on data collection for ICECaP2

Praful Ravi

Medical Oncology,
Dana-Farber Cancer Institute.

View Presentation

Example of assessing new PSA based endpoints

Wanling Xie

Biostatistics,
Dana-Farber Cancer Institute.

View Presentation

Progress on creating a health economics model in adjuvant prostate cancer setting

Richard De Abreu Lourenco

Health Ecocomics,
University of Technology Sydney

View Presentation

Discuss goal to credential QALY gained from preventing a PSA relapse as an endpoint

Chris Sweeney

ICECaP Principal Investigator,
Medical Oncology,
Dana-Farber Cancer Institute.

View Presentation

Progress of writing a guidance document for conduct of adjuvant trials

Anis Hamid

Medical Oncology, University of Melbourne

View Presentation

Progress on IPD data collection and network meta-analyses for treatment effects

Jayne Tierney

Evidence Synthesis
University College London

View Presentation

Progress on prognostic models and surrogacy

Susan Halabi

Biostatistics and Bioinformatics, Duke University

View Presentation

Proposal of simple prognostic model

Chris Sweeney

Medical Oncology
Dana-Farber Cancer Institute

View Presentation

ICECaP Biology 2021

Gerhardt Attard
Medical Oncology, Uni College London

Progress: prelim data, sample collection, and plans:

M1HSPC: STAMPEDE-ADT, doc, abi; CHAARTED; ENZAMET, PEACE-1
Adjuvant: STAMPEDE-ADT, doc, abi; NRG; ENZARAD